Novartis as a focused innovative medicines company
25 Years of Novartis – Continuing our innovation journey
Novartis Research & Development
Novartis – Who We Are
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
Novartis ‘focusing on high-end, innovative medicines,’ CEO says
Novartis Raises Outlook After Sandoz Generics Spinoff
Novartis Cancer Drug Is Approved With $475,000 Price Tag
Research and Development: It’s our heartbeat.
Novartis CEO on new cancer therapy programs
Novartis Life
Novartis Oncology - BOLD Science. Transforming Lives. Striving For Cures.
Novartis CEO discusses how AI will impact drug development
Novartis CEO on Acquisitions, AI, Weight-Loss Drugs
Novartis CEO Vas Narasimhan on The David Rubenstein Show
FDA approves Novartis gene therapy for rare genetic disorder
Manufacturing CAR-T Cell Therapies: The Novartis Approach
Novartis areas of focus
Novartis mission
Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine
novartis genel müdürlük
novartis
novartis hap nedir
novartis çalışanları maaşları
novartis ilaç nedir
novartis nedir
novartis ilaçları
novartis türkiye
novartis maaş
novartis ilaç
novartis şeker ilacı fiyatı